Bird flu vaccine trial begins

The A(H5N1) strain of bird flu is rapidly evolving and spreading among animal populations worldwide, prompting urgent action from health officials.

While the virus has yet to spread between humans, the new vaccine utilizes technology similar to that employed in COVID-19 jabs to provide a rapid response capability.

Researchers aim to determine the safety and efficacy of the vaccine in preventing infection from the highly pathogenic strain.

The trial is a critical step in pandemic preparedness as the virus continues to infect a growing number of species across Europe and North America.